Cargando…

Cancer and heart disease: associations and relations

Emerging evidence supports that cancer incidence is increased in patients with cardiovascular (CV) disease and heart failure (HF), and patients with HF frequently die from cancer. Recently, data have been generated showing that circulating factors in relation to HF promote tumour growth and developm...

Descripción completa

Detalles Bibliográficos
Autores principales:	de Boer, Rudolf A., Meijers, Wouter C., van der Meer, Peter, van Veldhuisen, Dirk J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons, Ltd 2019
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6988442/ https://www.ncbi.nlm.nih.gov/pubmed/31321851 http://dx.doi.org/10.1002/ejhf.1539

Ejemplares similares

Left atrial volume and left ventricular mass indices in heart failure with preserved and reduced ejection fraction
por: Gehlken, Carolin, et al.
Publicado: (2021)

Common risk factors for heart failure and cancer
por: Meijers, Wouter C, et al.
Publicado: (2019)

Comorbidities complicating heart failure: changes over the last 15 years
por: Screever, Elles M., et al.
Publicado: (2022)

Predictive value of plasma galectin-3 levels in heart failure with reduced and preserved ejection fraction
por: de Boer, Rudolf A, et al.
Publicado: (2011)

Low circulating microRNA levels in heart failure patients are associated with atherosclerotic disease and cardiovascular-related rehospitalizations
por: Vegter, Eline L., et al.
Publicado: (2017)

Iron Deficiency in Heart Failure: Mechanisms and Pathophysiology
por: Alnuwaysir, Ridha I. S., et al.
Publicado: (2021)

Diffuse Myocardial Fibrosis on Cardiac Magnetic Resonance Imaging Is Related to Galectin-3 and Predicts Outcome in Heart Failure
por: Screever, Elles M., et al.
Publicado: (2023)

ACE-inhibitors, Beta-blockers or the Combination in Heart Failure: Is It Just an A–B–C ?: EDITORIAL to: Effects of beta-blockade and ACE inhibition on B-type natriuretic peptides in stable patients with systolic heart failure by Rosenberg et al.
por: de Boer, Rudolf A., et al.
Publicado: (2008)

Galectin-3 in Cardiac Remodeling and Heart Failure
por: de Boer, Rudolf A., et al.
Publicado: (2010)

Erratum to: Galectin-3 in Cardiac Remodeling and Heart Failure
por: de Boer, Rudolf A., et al.
Publicado: (2012)

Diabetes, Glycemic Control, and New-Onset Heart Failure in Patients With Stable Coronary Artery Disease: Data from the Heart and Soul Study
por: van Melle, Joost P., et al.
Publicado: (2010)

Biomarker Profiles in Heart Failure Patients With Preserved and Reduced Ejection Fraction
por: Tromp, Jasper, et al.
Publicado: (2017)

Micronutrient deficiencies in heart failure: Mitochondrial dysfunction as a common pathophysiological mechanism?
por: Bomer, Nils, et al.
Publicado: (2022)

Aging, telomeres and heart failure
por: Wong, Liza S. M., et al.
Publicado: (2010)

Sexual dimorphism in selenium deficiency is associated with metabolic syndrome and prevalence of heart disease
por: Weening, Eerde H., et al.
Publicado: (2023)

Heart failure-associated anemia: bone marrow dysfunction and response to erythropoietin
por: Ruifrok, Willem-Peter T., et al.
Publicado: (2010)

The impact of coronary artery disease risk loci on ischemic heart failure severity and prognosis: association analysis in the COntrolled ROsuvastatin multiNAtional trial in heart failure (CORONA)
por: Haver, Vincent G, et al.
Publicado: (2014)

Patients with heart failure with preserved ejection fraction and low levels of natriuretic peptides
por: Meijers, W. C., et al.
Publicado: (2016)

Multifactorial Diseases of the Heart, Kidneys, Lungs, and Liver and Incident Cancer: Epidemiology and Shared Mechanisms
por: Shi, Canxia, et al.
Publicado: (2023)

Telomere Length of Circulating Leukocyte Subpopulations and Buccal Cells in Patients with Ischemic Heart Failure and Their Offspring
por: Wong, Liza S. M., et al.
Publicado: (2011)

Galectin-3 Activation and Inhibition in Heart Failure and Cardiovascular Disease: An Update
por: Suthahar, Navin, et al.
Publicado: (2018)

Multimarker profiling identifies protective and harmful immune processes in heart failure: findings from BIOSTAT-CHF
por: Markousis-Mavrogenis, George, et al.
Publicado: (2021)

Insulin‐like growth factor binding protein 7 (IGFBP7), a link between heart failure and senescence
por: Bracun, Valentina, et al.
Publicado: (2022)

Renal dysfunction is associated with shorter telomere length in heart failure
por: Wong, Liza S. M., et al.
Publicado: (2009)

Connecting epicardial adipose tissue and heart failure with preserved ejection fraction: mechanisms, management and modern perspectives
por: van Woerden, Gijs, et al.
Publicado: (2022)

Relative fat mass, a new index of adiposity, is strongly associated with incident heart failure: data from PREVEND
por: Suthahar, Navin, et al.
Publicado: (2022)

Fibroblast growth factor 23 mediates the association between iron deficiency and mortality in worsening heart failure
por: van der Wal, Haye H., et al.
Publicado: (2020)

Cardiac Transthyretin-derived Amyloidosis: An Emerging Target in Heart Failure with Preserved Ejection Fraction?
por: Klaassen, Sebastiaan HC, et al.
Publicado: (2020)

Heart failure with preserved ejection fraction, atrial fibrillation, and the role of senile amyloidosis
por: van den Berg, Maarten P, et al.
Publicado: (2019)

Could SGLT2 Inhibitors Improve Exercise Intolerance in Chronic Heart Failure?
por: Voorrips, Suzanne N., et al.
Publicado: (2022)

Bariatric surgery and cardiovascular disease: a systematic review and meta-analysis
por: van Veldhuisen, Sophie L, et al.
Publicado: (2022)

Heart Failure and Pancreas Exocrine Insufficiency: Pathophysiological Mechanisms and Clinical Point of View
por: Dams, Olivier C., et al.
Publicado: (2022)

Iron deficiency in worsening heart failure is associated with reduced estimated protein intake, fluid retention, inflammation, and antiplatelet use
por: van der Wal, Haye H, et al.
Publicado: (2019)

Biomarkers in heart failure with preserved ejection fraction
por: Meijers, W. C., et al.
Publicado: (2016)

Prognostic value of galectin-3, a novel marker of fibrosis, in patients with chronic heart failure: data from the DEAL-HF study
por: Lok, Dirk J. A., et al.
Publicado: (2010)

New roles for renin and prorenin in heart failure and cardiorenal crosstalk
por: Schroten, Nicolas F., et al.
Publicado: (2011)

ST2 and Galectin-3: Ready for Prime Time?
por: Meijers, Wouter C., et al.
Publicado: (2016)

Relationship between body mass index, cardiovascular biomarkers and incident heart failure
por: Suthahar, Navin, et al.
Publicado: (2021)

Progress in heart failure management in the Netherlands and beyond: long-term commitment to deliver high-quality research and patient care
por: Meems, L. M. G., et al.
Publicado: (2020)

Variability of biomarkers in patients with chronic heart failure and healthy controls
por: Meijers, Wouter C., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_7b27lgdn7tuv3h5h9l9re1dr76